The aim of the study was to identify the most frequent HLA haplotypes in order to optimize donor searches in unrelated hematopoietic stem cell (HSC) transplantation. Pediatric patients from the north of France who underwent initial HLA typing for donor search in our center were included. Patients and family members were broadly typed for HLA class I and II. Patients were further DNA typed at the sequence level for HLA-A, -B, -Cw, -DRB1, and -DQB1 alleles. In 200 of 207 patients HLA haplotypes were assigned by the mode of inheritance. The most common haplotypes were defined based on frequencies over 0.75%. Searches for unrelated donors were completed for 86 patients lacking a family donor. Matching criteria were either the optimal level of 10 alleles or a one-HLA class I mismatch as a second choice. Rates of successful search reach 85% for patients (n ¼ 20) who express at least one common five-allele (HLA-A/B/ Cw/DRB1/DQB1) haplotype, but also 77% for more patients (n ¼ 53) who express at least one of the 20 most frequent three-allele (HLA-A/B/Cw) haplotypes. Success rates are clearly less (39%) in patients lacking these haplotypes. The use of these data to delineate search strategies is discussed.
typing; donor search; multiallele haplotypes Transplantation of allogeneic hematopoietic stem cells (HSC) is increasingly performed in patients with high-risk leukemia or inherited disorders. [1] [2] [3] For patients lacking a genotypically HLA-matched sibling, an unrelated HSC transplantation can be proposed. [4] [5] [6] Historically, unrelated HSC transplantations were performed with donor/recipient pairs that were serologically identical for HLA-A, B, and DR antigens. [4] [5] [6] Estimates of HLA-ABDR haplotype frequencies have provided valuable information in calculating the chances of finding unrelated donors who were serologically identical to the recipients. 7, 8 More recently, accurate and reproducible high-resolution DNA-based typing methods have been developed. They revealed a far greater degree of polymorphism than the one detected by serology. Their use in clinical practice shows that mismatches for one or more alleles occur in about 40% of HLA-ABDR serologically matched donor-recipient pairs. [9] [10] [11] [12] [13] More importantly, several studies have shown that high-resolution HLA matching at HLA-A, -B, -Cw class I, and -DRB1, -DQB1 class II loci improves overall transplant outcome. [14] [15] [16] [17] [18] [19] [20] [21] [22] Thus, DNA typing on a sequence level for these five loci is now recommended to optimize the selection of well-matched unrelated donors.
The availability of matched donors at the genomic level largely depends on the representation of patient genotypes. Estimates of allele frequencies are available in various populations. 23, 24 However, these results have limitations in predicting the chance of finding matched-unrelated HSC donors because most haplotypes occur with different frequencies from those predicted by random distribution of their alleles. [25] [26] [27] [28] There are very few data on genomic haplotype frequencies (frequent vs rare or unique). Furthermore, in most studies, haplotype segregation is based on a probability calculation and not by family studies.
The aim of our work was to study the frequencies of HLA haplotypes instead of alleles in our region (north of France) and this was achieved by using family segregation analysis instead of probability calculations to define haplotypes with certainty. We then analyzed the relation between haplotype frequencies and rates of successful unrelated donor searches. The ultimate goal was to predict, for most patients, their chance of getting a genomic HLAmatched donor within a reasonable time. This could help to improve patient care. Knowledge of the most frequent haplotypes should also be used to delineate strategies to optimize donor searches.
Patients and methods

Patients
Patients (n ¼ 207) younger than 18 years old with advanced stage leukemia (n ¼ 150), severe aplastic anemia (n ¼ 26), genetic disorders (n ¼ 10), hemoglobinopathies (n ¼ 10), Langheran's cell histiocytosis (n ¼ 5), or other diseases (n ¼ 6) and with a need for HSC transplantation were eligible. All were living in the north of France and the majority of them were Caucasian. Patients and family members were initially typed for HLA-A and -B by means of standard serological methods and for HLA-Cw, -DRB1 and -DQB1 by low-resolution DNA typing. All patients underwent further HLA-A, -B, -Cw, -DRB1 and -DQB1 high-resolution DNA typing by PCR-SSP either before unrelated donor search when a genotypically HLA-matched sibling was not available or for the purpose of the study.
HLA serology
Serological testing was performed by standard techniques (One Lambda, Canoga Park, CA, USA). All HLA-A and -B specificities described in the 1998 WHO nomenclature report 29 were differentiated by serology. The specificities A69, A74, A80, B45, B49, B50, B64, B65, B71, B72, B46, B47, B48, B67, B73, B75, B76, B77, and B78 were confirmed by completing serology with low-resolution PCR-SSP (see below).
DNA typing
Low-resolution PCR-SSO (Innolipa Abbot France S.A, Rungis, France) typing of DRB1 and DQB1, low-resolution PCR-SSP (Dynal, Compie`gne or Olerup, Montfort L'Amaury, France) typing of HLA-A -B and -Cw, and high-resolution PCR-SSP (Dynal, Compie`gne or Olerup, Montfort L'Amaury, France) typing of HLA-A, -B, -Cw, -DRB1 and -DQB1 were performed by using the commercial kits according to the manufacturer's recommendations.
Donor search procedure
Blood samples from HLA-ABDR-matched donors from France and also from Western European and North American registries were asked for complementary genomic typing. When more than five donors were available, our strategy consisted of requesting the blood samples from five donors. Priority was given to donors with available HLA-A and -B split and/or -DRB1 high-resolution typing. When fewer than five donors were available, blood samples from five HLA-ABDR-matched donors or with one HLA class I mismatch (but no class II mismatch) were requested. The rational for this approach stems from our own experience and from other studies supporting that one HLA class I mismatch has no significant influence on clinical outcome in young patients. 30 After extended HLA-A/B/Cw/DRB1/ DQB1 molecular typing of the five donors, transplantation was always performed using the optimum HLA-compatible donor (HLA-A, -B, -Cw, -DRB1, and -DQB1 identical on a sequence level as the first choice or with one HLA class I mismatch as the second choice).
Results
Haplotype assignment
In total, 207 consecutive pediatric patients, who live in the north of France, underwent initial HLA-typing for HSC donor search from January 1999 to December 2001 in our center. As a first approach, patients, siblings, and parents were HLA-A, -B typed by serology and HLA-Cw, -DRB1 and -DQB1 typed by molecular methods at a low-resolution level for intrafamilial donor search. Haplotypes were assigned by the mode of inheritance after examination of HLA typing in the patient and in his or her parents. For the great majority of families (n ¼ 180) blood samples from both parents were available allowing an unambiguous identification of the four parental haplotypes. For 20 families, three instead of four haplotypes were identified per family because HLA typing was only feasible for one parent. Seven families were excluded from the study either because none of the parents could be typed (n ¼ 5) or because one recombination within the HLA region precluded haplotype assignment (n ¼ 2). Thus, the total number of studied haplotypes was 780 in patient families and 400 in patients.
Listing and genotypes of the most common HLA-ABDR haplotypes
Haplotype frequencies were calculated from the number of the particular haplotype/total number of haplotypes. For more clarity, these frequencies are expressed as percentages. In previous studies, common haplotypes were defined as multilocus haplotypes with frequencies over 0.4%, 8 1% 30 or 2%. 31 In the present study, haplotypes with frequencies equal to or over 0.75% were defined as the most common. The eight most common broad ABDR haplotypes are listed in Table 1 . As shown, their distribution within the 780 haplotypes identified in patient families and within the 400 haplotypes identified in patients are very similar. It is worth noting that these HLA-ABDR haplotypes are also found with high frequencies (by 1% or more) in Western European and/or North American registries with the exception of A1, B52, DR15 (data from Bone Marrow Donors Worldwide web site).
Genotypes of the eight most common HLA-ABDR haplotypes in our population were provided by highresolution typing of the 200 patients. As shown in Table 1 , HLA class I or II disparities occur among HLA-ABDRmatched individuals. Note that these disparities occur with variable rates depending on one haplotype to another. In each case, however, one genomic five-allele haplotype predominates. Those with frequencies over 0.75% are indicated in bold ( Table 1) .
Listing of the 20 most common three-alleles (HLA-A/B/Cw) haplotypes
The distribution of three-allele (HLA-A/B/Cw) haplotypes was also analyzed in the 200 patients. Frequencies of haplotypes were determined as described above. Threeallele haplotypes with frequencies equal to or over 0.75% are listed in Table 2 .
Rates of successful donor search in patients expressing at least one of the most common five-or three-allele haplotypes Figure 1a ).
The decision to stop or to continue the search when a highly compatible donor is not immediately found for the remaining patients is very difficult without any estimate of the chances of donor search success. We postulated that common three-allele haplotypes would be expressed in a greater proportion of patients compared to common fiveallele haplotypes and that expression of at least one of those would also be correlated with a high rate of a successful search. These hypotheses were confirmed by the results shown in Table 2 and Figure 1b . Among 86 patients, 53 (62%) expressed at least one of the 20 most common threeallele haplotypes listed in Table 2 ( Figure 1b ). An unrelated donor was found for 41 of these 53 (77%) patients. Donors were either matched at the optimal level of 10 alleles (n ¼ 33) or with one HLA class I mismatch (n ¼ 8). In contrast, the probability of finding a suitable donor is clearly less (ie 38%) in the 33 of 86 patients that do not express any of the 20 frequent three-allele haplotypes listed herein (Figure 1b) .
It is noteworthy that the rates of success were not increased (77%) by considering haplotypes with frequencies over 1%, but lowered (69%) when haplotypes with frequencies over 0.5% were taken into account.
Discussion
The relevance of common HLA-ABDR haplotypes to success rates of unrelated donor search, based on a broad match between donors and recipients has been previously evaluated. 8, 26 Results indicated that the probability of finding an HLA-ABDR matched 8 or an HLA-A/B/Cw/DRB1/DQB1-identical donor 26 is associated with the patients HLA-ABDR haplotype frequencies. Our results agree with these previous data in the sense that a matched donor was found for the great majority of patients with at least one common HLA-ABDR haplotype. Yet, extended HLA genotyping revealed Table 1 Listing and genotypes of the most common HLA-ABDR haplotypes that allelic dissociation is not exceptional even in the context of frequent haplotypes. However, one common five-allele haplotype predominates in these cases. As a consequence, an HLA-A/B/Cw/DRB1/DQB1-matched donor will be easier to find for patients who express a common HLA-ABDR haplotype consisting of the most frequent combination of alleles. For patients, with a less frequent combination of alleles, requesting more donor blood samples for complementary typing at the start of the search seems reasonable in order to decrease the delay in finding a donor. A minority of patients (23%) expressed a common HLA-ABDR haplotype. Before this study, one could not predict the chance of successful search for the remaining patients. The main finding reported herein is that the probability of getting a well-matched donor also reaches a very high level (77%) for a higher proportion of patients (62%) who expressed at least one common three-allele instead of one common five-allele haplotype. Since the end of this study (1st January 2002) and based on these data, our strategy for unrelated HSC donor search is to type HLA class I in addition to HLA class II alleles on a sequence level in patients prior to donor selection. From genomic typings, we estimate the number of donor blood samples to ask for. We also delineate the reasonable level of compatibility required between donor and recipient. The disease-free survival rate appears similar in young patients for which HLA incompatibility is limited to one HLA class I locus. 32 Therefore, for pediatric patients with advanced disease, finding one HLA class I-mismatched donor within a short time would be preferable to searching for a perfectly matched donor for a longer time. In this regard, it seems appropriate to search in a donor pool with one HLA broad mismatch when analysis of patient HLA genotype reveals that matching at the genomic level will be unlikely. As an example, this approach has already proved successful for one patient who expressed A*2302 on one haplotype and B*4402/Cw*0501 on the second haplotype instead of the A*2302/B*4403/Cw*1601 linked alleles on the same haplotype. In this case, one HLA-A-mismatched unrelated donor was found within a pool of five Ax (non-A23), B44 donors but not within a pool of five A23, B44 broadly typed donors. Finally, in a situation with a very low chance of finding a donor, cord blood transplantation could be an alternative for children.
HLA-ABDR
One cannot conclude from the present study that our search algorithm applies to patient populations from other geographic areas because of the variation in the distribution of alleles and phenotypes from one area to another. It should, however, partly apply to several Caucasian populations and primarily to Western European countries. Indeed, unrelated donors were found not only in the French registry (n ¼ 12) but also in English (n ¼ 5), German (n ¼ 19), and other Western European (n ¼ 4) or North American (n ¼ 14) registries. The high probability of identifying matched donors in these countries underscores the known genetic relationships between people living in these areas. In this regard, nine of the 20 most frequent HLA-A/B/Cw genomic haplotypes listed in this study correspond to known HLA-ABCw 'broad' associations found in conserved ancestral Caucasian haplotypes. 30 The most common HLA-A/B/Cw haplotypes found in our region might therefore derive, by recombination, from these conserved haplotypes and be shared by several Caucasian populations.
Of course, large-scale studies remain to be done worldwide for accurate determination of the frequencies of all multiallele haplotypes in any population and consequently accurate evaluation of probability of finding unrelated HSC donor for each patient. Meanwhile, the knowledge of the 20 most frequent three-allele (HLA-A/B/Cw) haplotypes listed in this study helps to predict the likelihood of finding a suitable unrelated donor in our region and probably in other Western European and North American countries to improve patient care and to delineate strategies to optimize donor search. Figure 1 Overall results of unrelated donor searches. In total, unrelated donor searches were made for 99 patients, interrupted 13 times and completed in 86. Only results of completed searches are reported. Matching criteria were either the optimal level of 10 alleles (10/10) or one-HLA class I mismatch (9/10) between unrelated donors and patients. Unrelated donors with one mismatch were HLA-A mismatch (n ¼ 10; nine at antigen and one at allele level), HLA-B mismatch (n ¼ 1 at antigen level) or HLA-Cw mismatch (n ¼ 4; one at antigen and three at allele level).
